Literature DB >> 25129200

Longitudinal trajectories of aberrant behavior in fragile X syndrome.

Kristin M Hustyi1, Scott S Hall2, Booil Jo3, Amy A Lightbody4, Allan L Reiss5.   

Abstract

The Aberrant Behavior Checklist-Community (ABC-C; Aman et al., 1995) has been increasingly adopted as a primary tool for measuring behavioral change in clinical trials for individuals with fragile X syndrome (FXS). To our knowledge, however, no study has documented the longitudinal trajectory of aberrant behaviors in individuals with FXS using the ABC-C. As part of a larger longitudinal study, we examined scores obtained on the ABC-C subscales for 124 children and adolescents (64 males, 60 females) with FXS who had two or more assessments (average interval between assessments was approximately 4 years). Concomitant changes in age-equivalent scores on the Vineland Adaptive Behavior Scales (VABS) were also examined. As expected for an X-linked genetic disorder, males with FXS obtained significantly higher scores on all subscales of the ABC-C and significantly lower age-equivalent scores on the VABS than females with FXS. In both males and females with FXS, scores on the Irritability/Agitation and Hyperactivity/Noncompliance subscales of the ABC-C decreased significantly with age, with little to no change occurring over time on the Lethargy/Social Withdrawal, Stereotypic Behavior, and Inappropriate Speech subscales. The decrease in scores on the Hyperactivity/Noncompliance domain was significantly greater for males than for females. In both males and females, age-equivalent scores on the VABS increased significantly over this developmental period. These results establish a basis upon which to evaluate long-term outcomes from intervention-based research. However, longitudinal direct observational studies are needed to establish whether the severity of problem behavior actually decreases over time in this population.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aberrant behavior; Adaptive behavior; Fragile X syndrome; Longitudinal data

Mesh:

Year:  2014        PMID: 25129200      PMCID: PMC4820327          DOI: 10.1016/j.ridd.2014.07.003

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  42 in total

1.  Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey.

Authors:  Donald B Bailey; Melissa Raspa; Ellen Bishop; Murrey Olmsted; Usha G Mallya; Elizabeth Berry-Kravis
Journal:  J Dev Behav Pediatr       Date:  2012-01       Impact factor: 2.225

2.  A comparison of the Aberrant Behavior Checklist and the GAF among adults with mental retardation and mental illness.

Authors:  Karen J Shedlack; John Hennen; Christine Magee; Daniel M Cheron
Journal:  Psychiatr Serv       Date:  2005-04       Impact factor: 3.084

3.  Behavioral phenotype of fragile X syndrome in adolescence and adulthood.

Authors:  Leann E Smith; Erin T Barker; Marsha Mailick Seltzer; Leonard Abbeduto; Jan S Greenberg
Journal:  Am J Intellect Dev Disabil       Date:  2012-01

4.  The trajectory of cognitive development in males with fragile X syndrome.

Authors:  E M Dykens; R M Hodapp; S Ort; B Finucane; L R Shapiro; J F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-05       Impact factor: 8.829

5.  Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome.

Authors:  Anne Wheeler; Melissa Raspa; Carla Bann; Ellen Bishop; David Hessl; Pat Sacco; Donald B Bailey
Journal:  Am J Med Genet A       Date:  2013-11-25       Impact factor: 2.802

6.  Emotional and behavioral problems in children and adolescents with and without intellectual disability.

Authors:  Marielle C Dekker; Hans M Koot; Jan van der Ende; Frank C Verhulst
Journal:  J Child Psychol Psychiatry       Date:  2002-11       Impact factor: 8.982

7.  Aberrant behaviors of young boys with fragile X syndrome.

Authors:  A M Lachiewicz; G A Spiridigliozzi; C M Gullion; S N Ransford; K Rao
Journal:  Am J Ment Retard       Date:  1994-03

8.  Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome.

Authors:  Scott S Hall; Amy A Lightbody; Allan L Reiss
Journal:  Am J Ment Retard       Date:  2008-01

Review 9.  The prevalence of aggression in genetic syndromes: a review.

Authors:  Laurie Powis; Chris Oliver
Journal:  Res Dev Disabil       Date:  2014-03-01

10.  Psychiatric symptoms in boys with fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder.

Authors:  Angela John Thurman; Andrea McDuffie; Randi Hagerman; Leonard Abbeduto
Journal:  Res Dev Disabil       Date:  2014-03-12
View more
  14 in total

1.  Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment.

Authors:  Leann E Smith; Jinkuk Hong; Jan S Greenberg; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2016-05

2.  Problem behaviour in adolescent boys with fragile X syndrome: relative prevalence, frequency and severity.

Authors:  S S Hall; R P Barnett; K M Hustyi
Journal:  J Intellect Disabil Res       Date:  2016-10-11

3.  A Description of the Educational Setting Among Individuals With Fragile X Syndrome.

Authors:  Rebecca Nash; Catharine Riley; Pangaja Paramsothy; Kendra Gilbertson; Melissa Raspa; Anne Wheeler; Eric J Dziuban; Georgina Peacock
Journal:  Am J Intellect Dev Disabil       Date:  2019-01

4.  Decreased home cage movement and oromotor impairments in adult Fmr1-KO mice.

Authors:  S J Bonasera; T R Chaudoin; E H Goulding; M Mittek; A Dunaevsky
Journal:  Genes Brain Behav       Date:  2017-03-29       Impact factor: 3.449

5.  Brain circuitry, behavior, and cognition: A randomized placebo-controlled trial of donepezil in fragile X syndrome.

Authors:  Jennifer L Bruno; Sm Hadi Hosseini; Amy A Lightbody; Mai K Manchanda; Allan L Reiss
Journal:  J Psychopharmacol       Date:  2019-07-02       Impact factor: 4.153

6.  Trajectories of Change in the Behavioral and Health Phenotype of Adolescents and Adults with Fragile X Syndrome and Intellectual Disability: Longitudinal Trends Over a Decade.

Authors:  Lauren V Usher; Leann S DaWalt; Jinkuk Hong; Jan S Greenberg; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2020-08

7.  Changes in Stereotypical Behavior Following Chlorpromazine Termination: Polypharmcy Effects on Response Class Membership.

Authors:  Maria G Valdovinos; Marisela Aguilar; Drew Piersma; Alyssa Wilkinson; Craig H Kennedy
Journal:  Adv Neurodev Disord       Date:  2020-05-20

8.  Autistic, Aberrant, and Food-Related Behaviors in Adolescents and Young Adults with Prader-Willi Syndrome: The Effects of Age and Genotype.

Authors:  Atsushi Ishii; Hiroshi Ihara; Hiroyuki Ogata; Masayuki Sayama; Masao Gito; Nobuyuki Murakami; Tadayuki Ayabe; Yuji Oto; Asami Takahashi; Toshiro Nagai
Journal:  Behav Neurol       Date:  2017-12-26       Impact factor: 3.342

Review 9.  Developmental studies in fragile X syndrome.

Authors:  Khaleel A Razak; Kelli C Dominick; Craig A Erickson
Journal:  J Neurodev Disord       Date:  2020-05-02       Impact factor: 4.025

10.  Metformin treatment in young children with fragile X syndrome.

Authors:  Hazel Maridith B Biag; Laura A Potter; Victoria Wilkins; Sumra Afzal; Alexis Rosvall; Maria Jimena Salcedo-Arellano; Akash Rajaratnam; Ramiro Manzano-Nunez; Andrea Schneider; Flora Tassone; Susan M Rivera; Randi J Hagerman
Journal:  Mol Genet Genomic Med       Date:  2019-09-14       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.